Allan C.  Golston net worth and biography

Allan Golston Biography and Net Worth

Director of Stryker
Mr. Golston is the President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston is also a director of Harley-Davidson, Inc., a manufacturer of motorcycles and accessories. 

Mr. Golston has extensive experience in auditing, finance and the healthcare industry. He is a certified public accountant and has held positions as a finance executive with Swedish Health Services (Seattle, WA) and the University of Colorado Hospital. In his service to the Gates Foundation, he has contributed to the strategic formation and operation of successful initiatives to provide healthcare, education and other human needs, all of which give him understanding that assists us in our global efforts to meet the needs of patients and caregivers. Mr. Golston's overall experience positions him well to serve as our Lead Independent Director and Compensation Committee Chair.

What is Allan C. Golston's net worth?

The estimated net worth of Allan C. Golston is at least $5.49 million as of February 2nd, 2024. Mr. Golston owns 14,242 shares of Stryker stock worth more than $5,492,855 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Golston may own. Learn More about Allan C. Golston's net worth.

How do I contact Allan C. Golston?

The corporate mailing address for Mr. Golston and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Allan C. Golston's contact information.

Has Allan C. Golston been buying or selling shares of Stryker?

Allan C. Golston has not been actively trading shares of Stryker within the last three months. Most recently, Allan C. Golston sold 3,273 shares of the business's stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $341.00, for a transaction totalling $1,116,093.00. Following the completion of the sale, the director now directly owns 14,242 shares of the company's stock, valued at $4,856,522. Learn More on Allan C. Golston's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (CEO), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), and Ronda Stryker (Director). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 10 times. They sold a total of 490,063 shares worth more than $165,955,919.20. The most recent insider tranaction occured on November, 7th when CEO Kevin Lobo sold 57,313 shares worth more than $21,131,303.10. Insiders at Stryker own 5.9% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 11/7/2024.

Allan C. Golston Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/2/2024Sell3,273$341.00$1,116,093.0014,242View SEC Filing Icon  
2/28/2023Sell5,459$263.27$1,437,190.9313,537View SEC Filing Icon  
5/29/2020Sell7,299$193.23$1,410,385.7713,972View SEC Filing Icon  
8/7/2019Sell3,399$209.84$713,246.1613,762View SEC Filing Icon  
See Full Table

Allan C. Golston Buying and Selling Activity at Stryker

This chart shows Allan C Golston's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $385.68
Low: $382.25
High: $390.00

50 Day Range

MA: $365.46
Low: $345.14
High: $390.08

2 Week Range

Now: $385.68
Low: $285.79
High: $398.20

Volume

1,063,118 shs

Average Volume

1,488,249 shs

Market Capitalization

$147.03 billion

P/E Ratio

41.34

Dividend Yield

0.82%

Beta

0.91